Tandem Diabetes Care, Inc.
TNDM
$0.07 (0.35%)
1D
1W
3M
1Y
5Y
ALL
Tandem Diabetes Care, Inc. is a global insulin delivery and diabetes technology company, which manufactures and sells advanced automated insulin delivery systems. Its pump portfolio features the Tandem Mobi system and the t:slim X2 insulin pump, both of which feature Control-IQ advanced hybrid closed-loop technology. Its t:slim X2 and Tandem Mobi pumps can be used with a variety of infusion sets to offer patients choice in how and where their pump is worn. In addition, they are software updatable from a personal computer and compatible with its Web-based data management application. Both pumps feature its Control-IQ advanced hybrid closed loop technology, with an automated insulin delivery (AID) feature designed to help increase a user's time in targeted glycemic range. There are two primary therapies used by people with insulin-dependent diabetes, Multiple Daily Injection (MDI) and insulin pumps. As part of it AID systems, it offers pump integration with multiple CGM sensors.
Open
Prior close
Today's high
Today's low
52 Week high
52 Week low
Zacks Investment Research • 28 days ago • TNDM
Does TNDM Stock Still Deserve a Place in Your Portfolio?
Business Wire • about a month ago • TNDM
Tandem Diabetes Care Launches t:slim X2 Insulin Pump Compatibility with Abbott FreeStyle Libre 3 Plus Sensor in Five International Markets
Business Wire • about a month ago • TNDM
Tandem Diabetes Care to Announce Second Quarter 2026 Financial Results on August 6, 2026
Seeking Alpha • about 2 months ago • TNDM
Tandem Diabetes Care, Inc. (TNDM) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript
Zacks Investment Research • about 2 months ago • TNDM
Wall Street Analysts See a 56.2% Upside in Tandem Diabetes Care (TNDM): Can the Stock Really Move This High?
Charts and pricing are provided for informational purposes only. The current market data is delayed up to 15 minutes. The accuracy of any market data displayed is not guaranteed.